Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials

Journal of Hepatology

Volumn 63, Issue 1, 2015, Pages 282-283

  Delatycki, Martin B ^a,b   Gurrin, Lyle C ^c   Ong, Sim Yee ^a   Ramm, Grant A ^d   Anderson, Greg J ^d   Olynyk, John K ^e,f,g   Allen, Katie J ^a,h   Nicoll, Amanda J ⁱ   Powell, Lawrie W ^d  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e FIONA STANLEY HOSPITAL   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g MURDOCH UNIVERSITY   (Australia)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ EASTERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; HFE PROTEIN; IRON; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; COLORECTAL CANCER; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; INTENTION TO TREAT ANALYSIS; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; LETTER; LIVER CANCER; MORTALITY; NORMAL VALUE; PHLEBOTOMY; PRIORITY JOURNAL; RISK REDUCTION; FEMALE; GENETICS; MALE;

FEMALE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS;

EID: 84931568695     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.03.028     Document Type: Letter

References (4)

1. E. Bardou-Jacquet, J. Morcet, G. Manet, F. Laine, M. Perrin, and A.M. Jouanolle Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis J Hepatol 62 2015 682 689
2. H. Zoller, and A. Finkenstedt Should C282Y homozygotes with mild iron overload be treated? J Hepatol 62 2015 510 511
3. N.J. Osborne, L.C. Gurrin, K.J. Allen, C.C. Constantine, M.B. Delatycki, and C.E. McLaren HFE C282Y homozygotes are at increased risk of breast and colorectal cancer Hepatology 51 2010 1311 1318
4. J.L. Sullivan Do hemochromatosis mutations protect against iron-mediated atherogenesis? Circ Cardiovasc Genet 2 2009 652 657